nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCB1—ulcerative colitis	0.112	1	CbGaD
Doxorubicin—NOS2—Dexamethasone—ulcerative colitis	0.0836	0.172	CbGbCtD
Doxorubicin—XDH—Mercaptopurine—ulcerative colitis	0.0738	0.151	CbGbCtD
Doxorubicin—XDH—Azathioprine—ulcerative colitis	0.0738	0.151	CbGbCtD
Doxorubicin—ABCC2—Sulfasalazine—ulcerative colitis	0.021	0.0431	CbGbCtD
Doxorubicin—ABCB11—Dexamethasone—ulcerative colitis	0.0199	0.0409	CbGbCtD
Doxorubicin—CYP1B1—Dexamethasone—ulcerative colitis	0.0199	0.0409	CbGbCtD
Doxorubicin—ABCG2—Sulfasalazine—ulcerative colitis	0.019	0.039	CbGbCtD
Doxorubicin—CYP2B6—Nicotine—ulcerative colitis	0.0172	0.0353	CbGbCtD
Doxorubicin—CYP2B6—Cholecalciferol—ulcerative colitis	0.0154	0.0316	CbGbCtD
Doxorubicin—ABCG2—Hydrocortisone—ulcerative colitis	0.0152	0.0313	CbGbCtD
Doxorubicin—CYP3A4—Budesonide—ulcerative colitis	0.0121	0.0249	CbGbCtD
Doxorubicin—NOS1—myenteric nerve plexus—ulcerative colitis	0.0117	0.134	CbGeAlD
Doxorubicin—ABCC2—Dexamethasone—ulcerative colitis	0.0105	0.0215	CbGbCtD
Doxorubicin—ABCG2—Dexamethasone—ulcerative colitis	0.00948	0.0195	CbGbCtD
Doxorubicin—ABCB1—Methylprednisolone—ulcerative colitis	0.00904	0.0186	CbGbCtD
Doxorubicin—ABCB11—bile duct—ulcerative colitis	0.00863	0.0988	CbGeAlD
Doxorubicin—CYP2D6—Nicotine—ulcerative colitis	0.0083	0.017	CbGbCtD
Doxorubicin—CYP2D6—Cholecalciferol—ulcerative colitis	0.00744	0.0153	CbGbCtD
Doxorubicin—CYP2B6—Dexamethasone—ulcerative colitis	0.00667	0.0137	CbGbCtD
Doxorubicin—ABCB11—bile—ulcerative colitis	0.00663	0.0759	CbGeAlD
Doxorubicin—ABCB1—Betamethasone—ulcerative colitis	0.00588	0.0121	CbGbCtD
Doxorubicin—ABCB1—Prednisolone—ulcerative colitis	0.0058	0.0119	CbGbCtD
Doxorubicin—ABCB1—Hydrocortisone—ulcerative colitis	0.0055	0.0113	CbGbCtD
Doxorubicin—ABCC3—bile duct—ulcerative colitis	0.00549	0.0629	CbGeAlD
Doxorubicin—ABCB1—Prednisone—ulcerative colitis	0.00548	0.0112	CbGbCtD
Doxorubicin—CYP3A4—Methylprednisolone—ulcerative colitis	0.00542	0.0111	CbGbCtD
Doxorubicin—CYP3A4—Nicotine—ulcerative colitis	0.00528	0.0108	CbGbCtD
Doxorubicin—CYP3A4—Cholecalciferol—ulcerative colitis	0.00473	0.00972	CbGbCtD
Doxorubicin—ABCC2—bile duct—ulcerative colitis	0.00439	0.0502	CbGeAlD
Doxorubicin—CYP3A4—Triamcinolone—ulcerative colitis	0.0041	0.00843	CbGbCtD
Doxorubicin—CYP3A4—Betamethasone—ulcerative colitis	0.00352	0.00723	CbGbCtD
Doxorubicin—CYP3A4—Prednisolone—ulcerative colitis	0.00347	0.00713	CbGbCtD
Doxorubicin—ABCB1—Dexamethasone—ulcerative colitis	0.00342	0.00702	CbGbCtD
Doxorubicin—ABCC2—bile—ulcerative colitis	0.00337	0.0386	CbGeAlD
Doxorubicin—CYP3A4—Hydrocortisone—ulcerative colitis	0.00329	0.00676	CbGbCtD
Doxorubicin—CYP3A4—Prednisone—ulcerative colitis	0.00328	0.00674	CbGbCtD
Doxorubicin—CYP2D6—Dexamethasone—ulcerative colitis	0.00322	0.00661	CbGbCtD
Doxorubicin—CYP3A4—Dexamethasone—ulcerative colitis	0.00205	0.00421	CbGbCtD
Doxorubicin—AKR1A1—smooth muscle tissue—ulcerative colitis	0.00149	0.017	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—ulcerative colitis	0.00119	0.0136	CbGeAlD
Doxorubicin—ABCB8—liver—ulcerative colitis	0.00118	0.0135	CbGeAlD
Doxorubicin—AKR1A1—digestive system—ulcerative colitis	0.00117	0.0134	CbGeAlD
Doxorubicin—NOS1—epithelium—ulcerative colitis	0.00117	0.0134	CbGeAlD
Doxorubicin—NOS1—smooth muscle tissue—ulcerative colitis	0.00113	0.0129	CbGeAlD
Doxorubicin—NDUFS2—smooth muscle tissue—ulcerative colitis	0.00112	0.0128	CbGeAlD
Doxorubicin—NDUFS3—smooth muscle tissue—ulcerative colitis	0.00111	0.0126	CbGeAlD
Doxorubicin—NDUFS7—digestive system—ulcerative colitis	0.00107	0.0122	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—ulcerative colitis	0.001	0.0115	CbGeAlD
Doxorubicin—AURKA—digestive system—ulcerative colitis	0.000991	0.0113	CbGeAlD
Doxorubicin—YWHAG—smooth muscle tissue—ulcerative colitis	0.000963	0.011	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—ulcerative colitis	0.000894	0.0102	CbGeAlD
Doxorubicin—NOS1—digestive system—ulcerative colitis	0.000889	0.0102	CbGeAlD
Doxorubicin—NOS3—epithelium—ulcerative colitis	0.000888	0.0102	CbGeAlD
Doxorubicin—NDUFS2—digestive system—ulcerative colitis	0.000883	0.0101	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—ulcerative colitis	0.000883	0.0101	CbGeAlD
Doxorubicin—AKR1A1—liver—ulcerative colitis	0.000874	0.01	CbGeAlD
Doxorubicin—NDUFS3—digestive system—ulcerative colitis	0.000873	0.00998	CbGeAlD
Doxorubicin—RALBP1—smooth muscle tissue—ulcerative colitis	0.00087	0.00996	CbGeAlD
Doxorubicin—NOS3—smooth muscle tissue—ulcerative colitis	0.000856	0.00979	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—ulcerative colitis	0.000839	0.0096	CbGeAlD
Doxorubicin—DHCR7—digestive system—ulcerative colitis	0.000829	0.00949	CbGeAlD
Doxorubicin—AKR1C3—smooth muscle tissue—ulcerative colitis	0.000802	0.00918	CbGeAlD
Doxorubicin—NDUFS7—liver—ulcerative colitis	0.000794	0.00909	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—ulcerative colitis	0.00077	0.00881	CbGeAlD
Doxorubicin—YWHAG—digestive system—ulcerative colitis	0.000761	0.0087	CbGeAlD
Doxorubicin—XDH—digestive system—ulcerative colitis	0.000742	0.00849	CbGeAlD
Doxorubicin—AURKA—liver—ulcerative colitis	0.000738	0.00845	CbGeAlD
Doxorubicin—ABCB11—digestive system—ulcerative colitis	0.000725	0.00829	CbGeAlD
Doxorubicin—RALBP1—digestive system—ulcerative colitis	0.000687	0.00786	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—ulcerative colitis	0.000684	0.00783	CbGeAlD
Doxorubicin—NOS3—digestive system—ulcerative colitis	0.000676	0.00773	CbGeAlD
Doxorubicin—NQO1—epithelium—ulcerative colitis	0.000675	0.00773	CbGeAlD
Doxorubicin—NDUFS2—liver—ulcerative colitis	0.000658	0.00753	CbGeAlD
Doxorubicin—NQO1—smooth muscle tissue—ulcerative colitis	0.000651	0.00745	CbGeAlD
Doxorubicin—NDUFS3—liver—ulcerative colitis	0.00065	0.00744	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—ulcerative colitis	0.000649	0.00743	CbGeAlD
Doxorubicin—CBR1—digestive system—ulcerative colitis	0.000641	0.00734	CbGeAlD
Doxorubicin—DHCR7—liver—ulcerative colitis	0.000618	0.00707	CbGeAlD
Doxorubicin—ABCC6—liver—ulcerative colitis	0.000602	0.00689	CbGeAlD
Doxorubicin—YWHAG—liver—ulcerative colitis	0.000567	0.00648	CbGeAlD
Doxorubicin—XDH—liver—ulcerative colitis	0.000553	0.00632	CbGeAlD
Doxorubicin—ABCB11—liver—ulcerative colitis	0.00054	0.00618	CbGeAlD
Doxorubicin—NQO1—digestive system—ulcerative colitis	0.000514	0.00588	CbGeAlD
Doxorubicin—RALBP1—liver—ulcerative colitis	0.000512	0.00586	CbGeAlD
Doxorubicin—NOS3—liver—ulcerative colitis	0.000504	0.00576	CbGeAlD
Doxorubicin—CBR1—liver—ulcerative colitis	0.000478	0.00547	CbGeAlD
Doxorubicin—AKR1C3—liver—ulcerative colitis	0.000472	0.0054	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—ulcerative colitis	0.000465	0.00532	CbGeAlD
Doxorubicin—ABCC3—digestive system—ulcerative colitis	0.000461	0.00528	CbGeAlD
Doxorubicin—ABCC10—digestive system—ulcerative colitis	0.000459	0.00525	CbGeAlD
Doxorubicin—CYP1B1—smooth muscle tissue—ulcerative colitis	0.000457	0.00523	CbGeAlD
Doxorubicin—POR—liver—ulcerative colitis	0.000431	0.00493	CbGeAlD
Doxorubicin—NQO1—liver—ulcerative colitis	0.000383	0.00438	CbGeAlD
Doxorubicin—ABCC2—digestive system—ulcerative colitis	0.000368	0.00422	CbGeAlD
Doxorubicin—CYP1B1—lymphoid tissue—ulcerative colitis	0.000365	0.00418	CbGeAlD
Doxorubicin—CYP1B1—digestive system—ulcerative colitis	0.000361	0.00413	CbGeAlD
Doxorubicin—ABCC3—liver—ulcerative colitis	0.000344	0.00393	CbGeAlD
Doxorubicin—AURKA—Calcipotriol—Cholecalciferol—ulcerative colitis	0.000342	0.0835	CbGdCrCtD
Doxorubicin—ABCC10—liver—ulcerative colitis	0.000342	0.00391	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Budesonide—ulcerative colitis	0.000275	0.067	CbGdCrCtD
Doxorubicin—ABCC2—liver—ulcerative colitis	0.000275	0.00314	CbGeAlD
Doxorubicin—CYP1B1—liver—ulcerative colitis	0.000269	0.00308	CbGeAlD
Doxorubicin—CYP2B6—lymphoid tissue—ulcerative colitis	0.000251	0.00287	CbGeAlD
Doxorubicin—CYP2B6—digestive system—ulcerative colitis	0.000248	0.00284	CbGeAlD
Doxorubicin—ABCC1—liver—ulcerative colitis	0.000242	0.00277	CbGeAlD
Doxorubicin—CBR3—Triamcinolone—Budesonide—ulcerative colitis	0.000227	0.0554	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Budesonide—ulcerative colitis	0.000208	0.0509	CbGdCrCtD
Doxorubicin—ABCG2—liver—ulcerative colitis	0.0002	0.00229	CbGeAlD
Doxorubicin—CYP3A4—digestive system—ulcerative colitis	0.000187	0.00214	CbGeAlD
Doxorubicin—CYP2B6—liver—ulcerative colitis	0.000185	0.00211	CbGeAlD
Doxorubicin—CYP2D6—digestive system—ulcerative colitis	0.000184	0.00211	CbGeAlD
Doxorubicin—ABCB1—epithelium—ulcerative colitis	0.000174	0.00199	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Hydrocortisone—ulcerative colitis	0.000141	0.0343	CbGdCrCtD
Doxorubicin—CYP3A4—liver—ulcerative colitis	0.000139	0.0016	CbGeAlD
Doxorubicin—CYP2D6—liver—ulcerative colitis	0.000137	0.00157	CbGeAlD
Doxorubicin—ABCB1—lymphoid tissue—ulcerative colitis	0.000134	0.00153	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Methylprednisolone—ulcerative colitis	0.000133	0.0324	CbGdCrCtD
Doxorubicin—ABCB1—digestive system—ulcerative colitis	0.000133	0.00152	CbGeAlD
Doxorubicin—CBR3—Fluorometholone—Betamethasone—ulcerative colitis	0.000131	0.0318	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Dexamethasone—ulcerative colitis	0.000131	0.0318	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Triamcinolone—ulcerative colitis	0.000128	0.0311	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisone—ulcerative colitis	0.000121	0.0295	CbGdCrCtD
Doxorubicin—CBR3—Fluorometholone—Prednisolone—ulcerative colitis	0.000118	0.0288	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Hydrocortisone—ulcerative colitis	0.000116	0.0283	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Budesonide—ulcerative colitis	0.000112	0.0274	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Budesonide—ulcerative colitis	0.000112	0.0274	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Methylprednisolone—ulcerative colitis	0.00011	0.0267	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Betamethasone—ulcerative colitis	0.000108	0.0263	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Dexamethasone—ulcerative colitis	0.000108	0.0263	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Methylprednisolone—ulcerative colitis	0.000101	0.0246	CbGdCrCtD
Doxorubicin—CBR3—Triamcinolone—Prednisone—ulcerative colitis	0.0001	0.0244	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Betamethasone—ulcerative colitis	9.91e-05	0.0242	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Dexamethasone—ulcerative colitis	9.91e-05	0.0242	CbGdCrCtD
Doxorubicin—ABCB1—liver—ulcerative colitis	9.87e-05	0.00113	CbGeAlD
Doxorubicin—CBR3—Triamcinolone—Prednisolone—ulcerative colitis	9.76e-05	0.0238	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Triamcinolone—ulcerative colitis	9.68e-05	0.0236	CbGdCrCtD
Doxorubicin—CBR3—Fluocinolone Acetonide—Prednisolone—ulcerative colitis	8.97e-05	0.0219	CbGdCrCtD
Doxorubicin—TOP2A—Methyldopa—Mesalazine—ulcerative colitis	7.04e-05	0.0172	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Hydrocortisone—ulcerative colitis	5.74e-05	0.014	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Hydrocortisone—ulcerative colitis	5.74e-05	0.014	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Methylprednisolone—ulcerative colitis	5.42e-05	0.0132	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Methylprednisolone—ulcerative colitis	5.42e-05	0.0132	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Dexamethasone—ulcerative colitis	5.33e-05	0.013	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Betamethasone—ulcerative colitis	5.33e-05	0.013	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Triamcinolone—ulcerative colitis	5.21e-05	0.0127	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Triamcinolone—ulcerative colitis	5.21e-05	0.0127	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisone—ulcerative colitis	4.94e-05	0.0121	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisone—ulcerative colitis	4.94e-05	0.0121	CbGdCrCtD
Doxorubicin—CBR3—Betamethasone—Prednisolone—ulcerative colitis	4.82e-05	0.0118	CbGdCrCtD
Doxorubicin—CBR3—Dexamethasone—Prednisolone—ulcerative colitis	4.82e-05	0.0118	CbGdCrCtD
Doxorubicin—Nervous system disorder—Hydrocortisone—ulcerative colitis	4.73e-05	0.000255	CcSEcCtD
Doxorubicin—Arthralgia—Methylprednisolone—ulcerative colitis	4.73e-05	0.000254	CcSEcCtD
Doxorubicin—Myalgia—Methylprednisolone—ulcerative colitis	4.73e-05	0.000254	CcSEcCtD
Doxorubicin—Eye disorder—Prednisone—ulcerative colitis	4.72e-05	0.000254	CcSEcCtD
Doxorubicin—Anxiety—Methylprednisolone—ulcerative colitis	4.71e-05	0.000253	CcSEcCtD
Doxorubicin—Tachycardia—Hydrocortisone—ulcerative colitis	4.71e-05	0.000253	CcSEcCtD
Doxorubicin—Rash—Azathioprine—ulcerative colitis	4.7e-05	0.000253	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.7e-05	0.000253	CcSEcCtD
Doxorubicin—Dermatitis—Azathioprine—ulcerative colitis	4.69e-05	0.000252	CcSEcCtD
Doxorubicin—Flushing—Prednisone—ulcerative colitis	4.69e-05	0.000252	CcSEcCtD
Doxorubicin—Skin disorder—Hydrocortisone—ulcerative colitis	4.69e-05	0.000252	CcSEcCtD
Doxorubicin—Ill-defined disorder—Dexamethasone—ulcerative colitis	4.69e-05	0.000252	CcSEcCtD
Doxorubicin—Ill-defined disorder—Betamethasone—ulcerative colitis	4.69e-05	0.000252	CcSEcCtD
Doxorubicin—Discomfort—Triamcinolone—ulcerative colitis	4.68e-05	0.000252	CcSEcCtD
Doxorubicin—Discomfort—Methylprednisolone—ulcerative colitis	4.67e-05	0.000251	CcSEcCtD
Doxorubicin—Headache—Azathioprine—ulcerative colitis	4.67e-05	0.000251	CcSEcCtD
Doxorubicin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.66e-05	0.000251	CcSEcCtD
Doxorubicin—Diarrhoea—Mesalazine—ulcerative colitis	4.64e-05	0.00025	CcSEcCtD
Doxorubicin—Dry mouth—Triamcinolone—ulcerative colitis	4.63e-05	0.000249	CcSEcCtD
Doxorubicin—Anorexia—Hydrocortisone—ulcerative colitis	4.6e-05	0.000247	CcSEcCtD
Doxorubicin—Angiopathy—Prednisone—ulcerative colitis	4.58e-05	0.000247	CcSEcCtD
Doxorubicin—Confusional state—Methylprednisolone—ulcerative colitis	4.57e-05	0.000246	CcSEcCtD
Doxorubicin—Immune system disorder—Prednisone—ulcerative colitis	4.56e-05	0.000246	CcSEcCtD
Doxorubicin—Malaise—Dexamethasone—ulcerative colitis	4.55e-05	0.000245	CcSEcCtD
Doxorubicin—Malaise—Betamethasone—ulcerative colitis	4.55e-05	0.000245	CcSEcCtD
Doxorubicin—Oedema—Triamcinolone—ulcerative colitis	4.54e-05	0.000244	CcSEcCtD
Doxorubicin—Anaphylactic shock—Triamcinolone—ulcerative colitis	4.54e-05	0.000244	CcSEcCtD
Doxorubicin—Vertigo—Dexamethasone—ulcerative colitis	4.54e-05	0.000244	CcSEcCtD
Doxorubicin—Vertigo—Betamethasone—ulcerative colitis	4.54e-05	0.000244	CcSEcCtD
Doxorubicin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	4.53e-05	0.000244	CcSEcCtD
Doxorubicin—Syncope—Dexamethasone—ulcerative colitis	4.53e-05	0.000244	CcSEcCtD
Doxorubicin—Syncope—Betamethasone—ulcerative colitis	4.53e-05	0.000244	CcSEcCtD
Doxorubicin—Arrhythmia—Prednisone—ulcerative colitis	4.51e-05	0.000243	CcSEcCtD
Doxorubicin—Infection—Triamcinolone—ulcerative colitis	4.51e-05	0.000243	CcSEcCtD
Doxorubicin—Hypotension—Hydrocortisone—ulcerative colitis	4.51e-05	0.000243	CcSEcCtD
Doxorubicin—Infection—Methylprednisolone—ulcerative colitis	4.5e-05	0.000242	CcSEcCtD
Doxorubicin—Dizziness—Mesalazine—ulcerative colitis	4.49e-05	0.000241	CcSEcCtD
Doxorubicin—Shock—Triamcinolone—ulcerative colitis	4.47e-05	0.00024	CcSEcCtD
Doxorubicin—Insomnia—Prednisolone—ulcerative colitis	4.47e-05	0.00024	CcSEcCtD
Doxorubicin—Alopecia—Prednisone—ulcerative colitis	4.46e-05	0.00024	CcSEcCtD
Doxorubicin—Shock—Methylprednisolone—ulcerative colitis	4.46e-05	0.00024	CcSEcCtD
Doxorubicin—Nervous system disorder—Methylprednisolone—ulcerative colitis	4.45e-05	0.000239	CcSEcCtD
Doxorubicin—Loss of consciousness—Betamethasone—ulcerative colitis	4.44e-05	0.000239	CcSEcCtD
Doxorubicin—Loss of consciousness—Dexamethasone—ulcerative colitis	4.44e-05	0.000239	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisolone—ulcerative colitis	4.44e-05	0.000239	CcSEcCtD
Doxorubicin—Tachycardia—Triamcinolone—ulcerative colitis	4.43e-05	0.000239	CcSEcCtD
Doxorubicin—Mental disorder—Prednisone—ulcerative colitis	4.43e-05	0.000238	CcSEcCtD
Doxorubicin—Nausea—Azathioprine—ulcerative colitis	4.42e-05	0.000238	CcSEcCtD
Doxorubicin—Tachycardia—Methylprednisolone—ulcerative colitis	4.42e-05	0.000238	CcSEcCtD
Doxorubicin—Skin disorder—Methylprednisolone—ulcerative colitis	4.4e-05	0.000237	CcSEcCtD
Doxorubicin—Malnutrition—Prednisone—ulcerative colitis	4.4e-05	0.000237	CcSEcCtD
Doxorubicin—Erythema—Prednisone—ulcerative colitis	4.4e-05	0.000237	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.4e-05	0.000236	CcSEcCtD
Doxorubicin—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.39e-05	0.000236	CcSEcCtD
Doxorubicin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.38e-05	0.000236	CcSEcCtD
Doxorubicin—Convulsion—Dexamethasone—ulcerative colitis	4.38e-05	0.000235	CcSEcCtD
Doxorubicin—Convulsion—Betamethasone—ulcerative colitis	4.38e-05	0.000235	CcSEcCtD
Doxorubicin—Insomnia—Hydrocortisone—ulcerative colitis	4.36e-05	0.000235	CcSEcCtD
Doxorubicin—Hypertension—Betamethasone—ulcerative colitis	4.36e-05	0.000235	CcSEcCtD
Doxorubicin—Hypertension—Dexamethasone—ulcerative colitis	4.36e-05	0.000235	CcSEcCtD
Doxorubicin—Paraesthesia—Hydrocortisone—ulcerative colitis	4.33e-05	0.000233	CcSEcCtD
Doxorubicin—Vomiting—Mesalazine—ulcerative colitis	4.31e-05	0.000232	CcSEcCtD
Doxorubicin—Myalgia—Betamethasone—ulcerative colitis	4.3e-05	0.000231	CcSEcCtD
Doxorubicin—Myalgia—Dexamethasone—ulcerative colitis	4.3e-05	0.000231	CcSEcCtD
Doxorubicin—Anxiety—Betamethasone—ulcerative colitis	4.28e-05	0.000231	CcSEcCtD
Doxorubicin—Anxiety—Dexamethasone—ulcerative colitis	4.28e-05	0.000231	CcSEcCtD
Doxorubicin—Rash—Mesalazine—ulcerative colitis	4.28e-05	0.00023	CcSEcCtD
Doxorubicin—Dermatitis—Mesalazine—ulcerative colitis	4.27e-05	0.00023	CcSEcCtD
Doxorubicin—Headache—Mesalazine—ulcerative colitis	4.25e-05	0.000229	CcSEcCtD
Doxorubicin—Discomfort—Betamethasone—ulcerative colitis	4.25e-05	0.000229	CcSEcCtD
Doxorubicin—Discomfort—Dexamethasone—ulcerative colitis	4.25e-05	0.000229	CcSEcCtD
Doxorubicin—Dyspepsia—Hydrocortisone—ulcerative colitis	4.25e-05	0.000228	CcSEcCtD
Doxorubicin—Hypotension—Methylprednisolone—ulcerative colitis	4.24e-05	0.000228	CcSEcCtD
Doxorubicin—Pain—Prednisolone—ulcerative colitis	4.22e-05	0.000227	CcSEcCtD
Doxorubicin—Decreased appetite—Hydrocortisone—ulcerative colitis	4.19e-05	0.000226	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	4.17e-05	0.000224	CcSEcCtD
Doxorubicin—Fatigue—Hydrocortisone—ulcerative colitis	4.16e-05	0.000224	CcSEcCtD
Doxorubicin—Vision blurred—Prednisone—ulcerative colitis	4.15e-05	0.000223	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.14e-05	0.000223	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.13e-05	0.000222	CcSEcCtD
Doxorubicin—Pain—Hydrocortisone—ulcerative colitis	4.13e-05	0.000222	CcSEcCtD
Doxorubicin—Oedema—Betamethasone—ulcerative colitis	4.12e-05	0.000222	CcSEcCtD
Doxorubicin—Oedema—Dexamethasone—ulcerative colitis	4.12e-05	0.000222	CcSEcCtD
Doxorubicin—Anaphylactic shock—Betamethasone—ulcerative colitis	4.12e-05	0.000222	CcSEcCtD
Doxorubicin—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.12e-05	0.000222	CcSEcCtD
Doxorubicin—Insomnia—Triamcinolone—ulcerative colitis	4.11e-05	0.000221	CcSEcCtD
Doxorubicin—Insomnia—Methylprednisolone—ulcerative colitis	4.1e-05	0.000221	CcSEcCtD
Doxorubicin—Infection—Betamethasone—ulcerative colitis	4.09e-05	0.00022	CcSEcCtD
Doxorubicin—Infection—Dexamethasone—ulcerative colitis	4.09e-05	0.00022	CcSEcCtD
Doxorubicin—Ill-defined disorder—Prednisone—ulcerative colitis	4.08e-05	0.00022	CcSEcCtD
Doxorubicin—Paraesthesia—Triamcinolone—ulcerative colitis	4.08e-05	0.000219	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisolone—ulcerative colitis	4.07e-05	0.000219	CcSEcCtD
Doxorubicin—Paraesthesia—Methylprednisolone—ulcerative colitis	4.07e-05	0.000219	CcSEcCtD
Doxorubicin—Anaemia—Prednisone—ulcerative colitis	4.07e-05	0.000219	CcSEcCtD
Doxorubicin—Shock—Dexamethasone—ulcerative colitis	4.06e-05	0.000218	CcSEcCtD
Doxorubicin—Shock—Betamethasone—ulcerative colitis	4.06e-05	0.000218	CcSEcCtD
Doxorubicin—Dyspnoea—Triamcinolone—ulcerative colitis	4.05e-05	0.000218	CcSEcCtD
Doxorubicin—Nervous system disorder—Dexamethasone—ulcerative colitis	4.04e-05	0.000217	CcSEcCtD
Doxorubicin—Nervous system disorder—Betamethasone—ulcerative colitis	4.04e-05	0.000217	CcSEcCtD
Doxorubicin—Agitation—Prednisone—ulcerative colitis	4.04e-05	0.000217	CcSEcCtD
Doxorubicin—Thrombocytopenia—Betamethasone—ulcerative colitis	4.04e-05	0.000217	CcSEcCtD
Doxorubicin—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.04e-05	0.000217	CcSEcCtD
Doxorubicin—Nausea—Mesalazine—ulcerative colitis	4.03e-05	0.000217	CcSEcCtD
Doxorubicin—Tachycardia—Dexamethasone—ulcerative colitis	4.02e-05	0.000216	CcSEcCtD
Doxorubicin—Tachycardia—Betamethasone—ulcerative colitis	4.02e-05	0.000216	CcSEcCtD
Doxorubicin—Dyspepsia—Triamcinolone—ulcerative colitis	4e-05	0.000215	CcSEcCtD
Doxorubicin—Dyspepsia—Methylprednisolone—ulcerative colitis	3.99e-05	0.000215	CcSEcCtD
Doxorubicin—Hyperhidrosis—Betamethasone—ulcerative colitis	3.98e-05	0.000214	CcSEcCtD
Doxorubicin—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.98e-05	0.000214	CcSEcCtD
Doxorubicin—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.98e-05	0.000214	CcSEcCtD
Doxorubicin—Malaise—Prednisone—ulcerative colitis	3.97e-05	0.000213	CcSEcCtD
Doxorubicin—Vertigo—Prednisone—ulcerative colitis	3.95e-05	0.000213	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.95e-05	0.000212	CcSEcCtD
Doxorubicin—Syncope—Prednisone—ulcerative colitis	3.94e-05	0.000212	CcSEcCtD
Doxorubicin—Anorexia—Dexamethasone—ulcerative colitis	3.93e-05	0.000211	CcSEcCtD
Doxorubicin—Anorexia—Betamethasone—ulcerative colitis	3.93e-05	0.000211	CcSEcCtD
Doxorubicin—Urticaria—Prednisolone—ulcerative colitis	3.92e-05	0.000211	CcSEcCtD
Doxorubicin—Fatigue—Triamcinolone—ulcerative colitis	3.92e-05	0.000211	CcSEcCtD
Doxorubicin—Fatigue—Methylprednisolone—ulcerative colitis	3.91e-05	0.00021	CcSEcCtD
Doxorubicin—Pain—Triamcinolone—ulcerative colitis	3.88e-05	0.000209	CcSEcCtD
Doxorubicin—Loss of consciousness—Prednisone—ulcerative colitis	3.87e-05	0.000208	CcSEcCtD
Doxorubicin—Hypotension—Dexamethasone—ulcerative colitis	3.85e-05	0.000207	CcSEcCtD
Doxorubicin—Hypotension—Betamethasone—ulcerative colitis	3.85e-05	0.000207	CcSEcCtD
Doxorubicin—Urticaria—Hydrocortisone—ulcerative colitis	3.83e-05	0.000206	CcSEcCtD
Doxorubicin—Abdominal pain—Hydrocortisone—ulcerative colitis	3.81e-05	0.000205	CcSEcCtD
Doxorubicin—Body temperature increased—Hydrocortisone—ulcerative colitis	3.81e-05	0.000205	CcSEcCtD
Doxorubicin—Convulsion—Prednisone—ulcerative colitis	3.81e-05	0.000205	CcSEcCtD
Doxorubicin—Hypertension—Prednisone—ulcerative colitis	3.8e-05	0.000204	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.76e-05	0.000202	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.76e-05	0.000202	CcSEcCtD
Doxorubicin—Arthralgia—Prednisone—ulcerative colitis	3.74e-05	0.000201	CcSEcCtD
Doxorubicin—Myalgia—Prednisone—ulcerative colitis	3.74e-05	0.000201	CcSEcCtD
Doxorubicin—Feeling abnormal—Triamcinolone—ulcerative colitis	3.74e-05	0.000201	CcSEcCtD
Doxorubicin—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.74e-05	0.000201	CcSEcCtD
Doxorubicin—Anxiety—Prednisone—ulcerative colitis	3.73e-05	0.000201	CcSEcCtD
Doxorubicin—Insomnia—Betamethasone—ulcerative colitis	3.73e-05	0.000201	CcSEcCtD
Doxorubicin—Insomnia—Dexamethasone—ulcerative colitis	3.73e-05	0.000201	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.72e-05	0.0002	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.71e-05	0.000199	CcSEcCtD
Doxorubicin—Paraesthesia—Betamethasone—ulcerative colitis	3.7e-05	0.000199	CcSEcCtD
Doxorubicin—Paraesthesia—Dexamethasone—ulcerative colitis	3.7e-05	0.000199	CcSEcCtD
Doxorubicin—Discomfort—Prednisone—ulcerative colitis	3.7e-05	0.000199	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisolone—ulcerative colitis	3.64e-05	0.000196	CcSEcCtD
Doxorubicin—Dyspepsia—Dexamethasone—ulcerative colitis	3.63e-05	0.000195	CcSEcCtD
Doxorubicin—Dyspepsia—Betamethasone—ulcerative colitis	3.63e-05	0.000195	CcSEcCtD
Doxorubicin—Urticaria—Triamcinolone—ulcerative colitis	3.61e-05	0.000194	CcSEcCtD
Doxorubicin—Urticaria—Methylprednisolone—ulcerative colitis	3.6e-05	0.000194	CcSEcCtD
Doxorubicin—Body temperature increased—Triamcinolone—ulcerative colitis	3.59e-05	0.000193	CcSEcCtD
Doxorubicin—Oedema—Prednisone—ulcerative colitis	3.59e-05	0.000193	CcSEcCtD
Doxorubicin—Anaphylactic shock—Prednisone—ulcerative colitis	3.59e-05	0.000193	CcSEcCtD
Doxorubicin—Abdominal pain—Methylprednisolone—ulcerative colitis	3.58e-05	0.000193	CcSEcCtD
Doxorubicin—Decreased appetite—Betamethasone—ulcerative colitis	3.58e-05	0.000193	CcSEcCtD
Doxorubicin—Decreased appetite—Dexamethasone—ulcerative colitis	3.58e-05	0.000193	CcSEcCtD
Doxorubicin—Infection—Prednisone—ulcerative colitis	3.57e-05	0.000192	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.56e-05	0.000191	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.56e-05	0.000191	CcSEcCtD
Doxorubicin—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.55e-05	0.000191	CcSEcCtD
Doxorubicin—Fatigue—Dexamethasone—ulcerative colitis	3.55e-05	0.000191	CcSEcCtD
Doxorubicin—Fatigue—Betamethasone—ulcerative colitis	3.55e-05	0.000191	CcSEcCtD
Doxorubicin—Shock—Prednisone—ulcerative colitis	3.53e-05	0.00019	CcSEcCtD
Doxorubicin—Pain—Dexamethasone—ulcerative colitis	3.52e-05	0.00019	CcSEcCtD
Doxorubicin—Pain—Betamethasone—ulcerative colitis	3.52e-05	0.00019	CcSEcCtD
Doxorubicin—Nervous system disorder—Prednisone—ulcerative colitis	3.52e-05	0.000189	CcSEcCtD
Doxorubicin—Tachycardia—Prednisone—ulcerative colitis	3.5e-05	0.000188	CcSEcCtD
Doxorubicin—Skin disorder—Prednisone—ulcerative colitis	3.49e-05	0.000188	CcSEcCtD
Doxorubicin—Hyperhidrosis—Prednisone—ulcerative colitis	3.47e-05	0.000187	CcSEcCtD
Doxorubicin—Asthenia—Hydrocortisone—ulcerative colitis	3.46e-05	0.000186	CcSEcCtD
Doxorubicin—Anorexia—Prednisone—ulcerative colitis	3.42e-05	0.000184	CcSEcCtD
Doxorubicin—Pruritus—Hydrocortisone—ulcerative colitis	3.41e-05	0.000184	CcSEcCtD
Doxorubicin—Feeling abnormal—Dexamethasone—ulcerative colitis	3.4e-05	0.000183	CcSEcCtD
Doxorubicin—Feeling abnormal—Betamethasone—ulcerative colitis	3.4e-05	0.000183	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.37e-05	0.000181	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.37e-05	0.000181	CcSEcCtD
Doxorubicin—Hypersensitivity—Triamcinolone—ulcerative colitis	3.35e-05	0.00018	CcSEcCtD
Doxorubicin—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.34e-05	0.00018	CcSEcCtD
Doxorubicin—Diarrhoea—Hydrocortisone—ulcerative colitis	3.3e-05	0.000178	CcSEcCtD
Doxorubicin—Urticaria—Betamethasone—ulcerative colitis	3.27e-05	0.000176	CcSEcCtD
Doxorubicin—Urticaria—Dexamethasone—ulcerative colitis	3.27e-05	0.000176	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.27e-05	0.000176	CcSEcCtD
Doxorubicin—Dizziness—Prednisolone—ulcerative colitis	3.27e-05	0.000176	CcSEcCtD
Doxorubicin—Asthenia—Triamcinolone—ulcerative colitis	3.26e-05	0.000175	CcSEcCtD
Doxorubicin—Abdominal pain—Betamethasone—ulcerative colitis	3.26e-05	0.000175	CcSEcCtD
Doxorubicin—Body temperature increased—Dexamethasone—ulcerative colitis	3.26e-05	0.000175	CcSEcCtD
Doxorubicin—Abdominal pain—Dexamethasone—ulcerative colitis	3.26e-05	0.000175	CcSEcCtD
Doxorubicin—Body temperature increased—Betamethasone—ulcerative colitis	3.26e-05	0.000175	CcSEcCtD
Doxorubicin—Asthenia—Methylprednisolone—ulcerative colitis	3.25e-05	0.000175	CcSEcCtD
Doxorubicin—Insomnia—Prednisone—ulcerative colitis	3.25e-05	0.000175	CcSEcCtD
Doxorubicin—Paraesthesia—Prednisone—ulcerative colitis	3.22e-05	0.000173	CcSEcCtD
Doxorubicin—Pruritus—Triamcinolone—ulcerative colitis	3.21e-05	0.000173	CcSEcCtD
Doxorubicin—Pruritus—Methylprednisolone—ulcerative colitis	3.21e-05	0.000173	CcSEcCtD
Doxorubicin—Dizziness—Hydrocortisone—ulcerative colitis	3.19e-05	0.000172	CcSEcCtD
Doxorubicin—Dyspepsia—Prednisone—ulcerative colitis	3.16e-05	0.00017	CcSEcCtD
Doxorubicin—Decreased appetite—Prednisone—ulcerative colitis	3.12e-05	0.000168	CcSEcCtD
Doxorubicin—Rash—Prednisolone—ulcerative colitis	3.11e-05	0.000168	CcSEcCtD
Doxorubicin—Dermatitis—Prednisolone—ulcerative colitis	3.11e-05	0.000167	CcSEcCtD
Doxorubicin—Diarrhoea—Methylprednisolone—ulcerative colitis	3.1e-05	0.000167	CcSEcCtD
Doxorubicin—Fatigue—Prednisone—ulcerative colitis	3.09e-05	0.000166	CcSEcCtD
Doxorubicin—Headache—Prednisolone—ulcerative colitis	3.09e-05	0.000166	CcSEcCtD
Doxorubicin—Constipation—Prednisone—ulcerative colitis	3.07e-05	0.000165	CcSEcCtD
Doxorubicin—Vomiting—Hydrocortisone—ulcerative colitis	3.07e-05	0.000165	CcSEcCtD
Doxorubicin—Rash—Hydrocortisone—ulcerative colitis	3.04e-05	0.000164	CcSEcCtD
Doxorubicin—Dermatitis—Hydrocortisone—ulcerative colitis	3.04e-05	0.000163	CcSEcCtD
Doxorubicin—Headache—Hydrocortisone—ulcerative colitis	3.02e-05	0.000163	CcSEcCtD
Doxorubicin—Dizziness—Triamcinolone—ulcerative colitis	3e-05	0.000162	CcSEcCtD
Doxorubicin—Dizziness—Methylprednisolone—ulcerative colitis	3e-05	0.000161	CcSEcCtD
Doxorubicin—Feeling abnormal—Prednisone—ulcerative colitis	2.96e-05	0.000159	CcSEcCtD
Doxorubicin—Asthenia—Betamethasone—ulcerative colitis	2.96e-05	0.000159	CcSEcCtD
Doxorubicin—Asthenia—Dexamethasone—ulcerative colitis	2.96e-05	0.000159	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Prednisone—ulcerative colitis	2.94e-05	0.000158	CcSEcCtD
Doxorubicin—Nausea—Prednisolone—ulcerative colitis	2.93e-05	0.000158	CcSEcCtD
Doxorubicin—Pruritus—Betamethasone—ulcerative colitis	2.92e-05	0.000157	CcSEcCtD
Doxorubicin—Pruritus—Dexamethasone—ulcerative colitis	2.92e-05	0.000157	CcSEcCtD
Doxorubicin—Vomiting—Triamcinolone—ulcerative colitis	2.89e-05	0.000155	CcSEcCtD
Doxorubicin—Vomiting—Methylprednisolone—ulcerative colitis	2.88e-05	0.000155	CcSEcCtD
Doxorubicin—Nausea—Hydrocortisone—ulcerative colitis	2.87e-05	0.000154	CcSEcCtD
Doxorubicin—Rash—Triamcinolone—ulcerative colitis	2.86e-05	0.000154	CcSEcCtD
Doxorubicin—Dermatitis—Triamcinolone—ulcerative colitis	2.86e-05	0.000154	CcSEcCtD
Doxorubicin—Rash—Methylprednisolone—ulcerative colitis	2.86e-05	0.000154	CcSEcCtD
Doxorubicin—Dermatitis—Methylprednisolone—ulcerative colitis	2.86e-05	0.000154	CcSEcCtD
Doxorubicin—Urticaria—Prednisone—ulcerative colitis	2.85e-05	0.000153	CcSEcCtD
Doxorubicin—Headache—Triamcinolone—ulcerative colitis	2.85e-05	0.000153	CcSEcCtD
Doxorubicin—Headache—Methylprednisolone—ulcerative colitis	2.84e-05	0.000153	CcSEcCtD
Doxorubicin—Abdominal pain—Prednisone—ulcerative colitis	2.84e-05	0.000153	CcSEcCtD
Doxorubicin—Body temperature increased—Prednisone—ulcerative colitis	2.84e-05	0.000153	CcSEcCtD
Doxorubicin—Diarrhoea—Dexamethasone—ulcerative colitis	2.82e-05	0.000152	CcSEcCtD
Doxorubicin—Diarrhoea—Betamethasone—ulcerative colitis	2.82e-05	0.000152	CcSEcCtD
Doxorubicin—Dizziness—Betamethasone—ulcerative colitis	2.73e-05	0.000147	CcSEcCtD
Doxorubicin—Dizziness—Dexamethasone—ulcerative colitis	2.73e-05	0.000147	CcSEcCtD
Doxorubicin—Nausea—Triamcinolone—ulcerative colitis	2.7e-05	0.000145	CcSEcCtD
Doxorubicin—Nausea—Methylprednisolone—ulcerative colitis	2.69e-05	0.000145	CcSEcCtD
Doxorubicin—Hypersensitivity—Prednisone—ulcerative colitis	2.64e-05	0.000142	CcSEcCtD
Doxorubicin—Vomiting—Betamethasone—ulcerative colitis	2.62e-05	0.000141	CcSEcCtD
Doxorubicin—Vomiting—Dexamethasone—ulcerative colitis	2.62e-05	0.000141	CcSEcCtD
Doxorubicin—Rash—Dexamethasone—ulcerative colitis	2.6e-05	0.00014	CcSEcCtD
Doxorubicin—Rash—Betamethasone—ulcerative colitis	2.6e-05	0.00014	CcSEcCtD
Doxorubicin—Dermatitis—Dexamethasone—ulcerative colitis	2.6e-05	0.00014	CcSEcCtD
Doxorubicin—Dermatitis—Betamethasone—ulcerative colitis	2.6e-05	0.00014	CcSEcCtD
Doxorubicin—Headache—Dexamethasone—ulcerative colitis	2.58e-05	0.000139	CcSEcCtD
Doxorubicin—Headache—Betamethasone—ulcerative colitis	2.58e-05	0.000139	CcSEcCtD
Doxorubicin—Asthenia—Prednisone—ulcerative colitis	2.58e-05	0.000139	CcSEcCtD
Doxorubicin—Pruritus—Prednisone—ulcerative colitis	2.54e-05	0.000137	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Hydrocortisone—ulcerative colitis	2.5e-05	0.00611	CbGdCrCtD
Doxorubicin—Diarrhoea—Prednisone—ulcerative colitis	2.46e-05	0.000132	CcSEcCtD
Doxorubicin—Nausea—Betamethasone—ulcerative colitis	2.45e-05	0.000132	CcSEcCtD
Doxorubicin—Nausea—Dexamethasone—ulcerative colitis	2.45e-05	0.000132	CcSEcCtD
Doxorubicin—Dizziness—Prednisone—ulcerative colitis	2.37e-05	0.000128	CcSEcCtD
Doxorubicin—Vomiting—Prednisone—ulcerative colitis	2.28e-05	0.000123	CcSEcCtD
Doxorubicin—Rash—Prednisone—ulcerative colitis	2.26e-05	0.000122	CcSEcCtD
Doxorubicin—Dermatitis—Prednisone—ulcerative colitis	2.26e-05	0.000122	CcSEcCtD
Doxorubicin—Headache—Prednisone—ulcerative colitis	2.25e-05	0.000121	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisone—ulcerative colitis	2.15e-05	0.00526	CbGdCrCtD
Doxorubicin—Nausea—Prednisone—ulcerative colitis	2.13e-05	0.000115	CcSEcCtD
Doxorubicin—TOP2A—Methyltestosterone—Prednisolone—ulcerative colitis	2.1e-05	0.00513	CbGdCrCtD
Doxorubicin—RALBP1—Signaling Pathways—ADCY5—ulcerative colitis	1.95e-05	0.000158	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.95e-05	0.000158	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.94e-05	0.000158	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—ALB—ulcerative colitis	1.94e-05	0.000158	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL20—ulcerative colitis	1.92e-05	0.000156	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR6—ulcerative colitis	1.91e-05	0.000155	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—TGFB1—ulcerative colitis	1.9e-05	0.000155	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—IL2—ulcerative colitis	1.89e-05	0.000153	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	1.88e-05	0.000153	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL2—ulcerative colitis	1.88e-05	0.000152	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—DLD—ulcerative colitis	1.85e-05	0.000151	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CALM3—ulcerative colitis	1.85e-05	0.00015	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS1—ulcerative colitis	1.84e-05	0.000149	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PPARG—ulcerative colitis	1.83e-05	0.000149	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.81e-05	0.000147	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAML2—ulcerative colitis	1.81e-05	0.000147	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GNA12—ulcerative colitis	1.81e-05	0.000147	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—ALB—ulcerative colitis	1.81e-05	0.000147	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PTGS2—ulcerative colitis	1.81e-05	0.000147	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PTGS2—ulcerative colitis	1.81e-05	0.000147	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.8e-05	0.000147	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CALM3—ulcerative colitis	1.8e-05	0.000146	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CALM3—ulcerative colitis	1.78e-05	0.000145	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.75e-05	0.000142	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—ulcerative colitis	1.73e-05	0.000141	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCR2—ulcerative colitis	1.71e-05	0.000139	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PPARG—ulcerative colitis	1.71e-05	0.000139	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.7e-05	0.000138	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PTGS2—ulcerative colitis	1.7e-05	0.000138	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTGER4—ulcerative colitis	1.68e-05	0.000137	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ADCY5—ulcerative colitis	1.68e-05	0.000136	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—JAK2—ulcerative colitis	1.68e-05	0.000136	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS1—ulcerative colitis	1.67e-05	0.000136	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CALM3—ulcerative colitis	1.66e-05	0.000135	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—ALB—ulcerative colitis	1.65e-05	0.000134	CbGpPWpGaD
Doxorubicin—TOP2A—Norethindrone—Hydrocortisone—ulcerative colitis	1.63e-05	0.00398	CbGdCrCtD
Doxorubicin—NOS3—Signaling Pathways—CCR6—ulcerative colitis	1.61e-05	0.000131	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—ulcerative colitis	1.61e-05	0.00013	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—IL6—ulcerative colitis	1.59e-05	0.000129	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CHP1—ulcerative colitis	1.57e-05	0.000128	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ADCY5—ulcerative colitis	1.54e-05	0.000125	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.54e-05	0.000125	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—ALB—ulcerative colitis	1.54e-05	0.000125	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GHRL—ulcerative colitis	1.54e-05	0.000125	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAML2—ulcerative colitis	1.53e-05	0.000124	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.52e-05	0.000124	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CALM3—ulcerative colitis	1.51e-05	0.000122	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CALM3—ulcerative colitis	1.49e-05	0.000121	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.48e-05	0.000121	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SLC11A1—ulcerative colitis	1.48e-05	0.00012	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—ulcerative colitis	1.47e-05	0.00012	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TGFB1—ulcerative colitis	1.47e-05	0.00012	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RIPK2—ulcerative colitis	1.47e-05	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL2—ulcerative colitis	1.46e-05	0.000119	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	1.46e-05	0.000119	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PTGS2—ulcerative colitis	1.44e-05	0.000117	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.44e-05	0.000117	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ABCB1—ulcerative colitis	1.44e-05	0.000117	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.42e-05	0.000116	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.42e-05	0.000115	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTGER4—ulcerative colitis	1.42e-05	0.000115	CbGpPWpGaD
Doxorubicin—NOS1—Disease—JAK2—ulcerative colitis	1.39e-05	0.000113	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ABCB1—ulcerative colitis	1.39e-05	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TNF—ulcerative colitis	1.37e-05	0.000111	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—DLD—ulcerative colitis	1.36e-05	0.00011	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS1—ulcerative colitis	1.36e-05	0.00011	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTGS2—ulcerative colitis	1.35e-05	0.000109	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.34e-05	0.000109	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ADCY5—ulcerative colitis	1.34e-05	0.000109	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.33e-05	0.000108	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAML2—ulcerative colitis	1.33e-05	0.000108	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—ulcerative colitis	1.32e-05	0.000107	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTGS2—ulcerative colitis	1.31e-05	0.000106	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ADCY5—ulcerative colitis	1.3e-05	0.000106	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS1—ulcerative colitis	1.3e-05	0.000106	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GHRL—ulcerative colitis	1.3e-05	0.000106	CbGpPWpGaD
Doxorubicin—TOP2A—Levonorgestrel—Hydrocortisone—ulcerative colitis	1.3e-05	0.00317	CbGdCrCtD
Doxorubicin—AKR1C3—Metabolism—ADCY5—ulcerative colitis	1.29e-05	0.000105	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ABCB1—ulcerative colitis	1.29e-05	0.000105	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.28e-05	0.000104	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADRB2—ulcerative colitis	1.27e-05	0.000103	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.26e-05	0.000102	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CALM3—ulcerative colitis	1.26e-05	0.000102	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.25e-05	0.000102	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RIPK2—ulcerative colitis	1.24e-05	0.000101	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CALM3—ulcerative colitis	1.22e-05	9.92e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.22e-05	9.88e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—JAK2—ulcerative colitis	1.22e-05	9.88e-05	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—ulcerative colitis	1.21e-05	9.84e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ADCY5—ulcerative colitis	1.2e-05	9.76e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RELA—ulcerative colitis	1.18e-05	9.57e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CALM3—ulcerative colitis	1.17e-05	9.51e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ABCB1—ulcerative colitis	1.17e-05	9.51e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.17e-05	9.48e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CHP1—ulcerative colitis	1.16e-05	9.44e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—ulcerative colitis	1.14e-05	9.28e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.12e-05	9.09e-05	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—ulcerative colitis	1.12e-05	9.08e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.11e-05	9.05e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CXCL8—ulcerative colitis	1.11e-05	9.02e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CALM3—ulcerative colitis	1.1e-05	8.9e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.09e-05	8.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ADCY5—ulcerative colitis	1.09e-05	8.87e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADCY5—ulcerative colitis	1.08e-05	8.78e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.08e-05	8.76e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADRB2—ulcerative colitis	1.08e-05	8.74e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—ulcerative colitis	1.06e-05	8.62e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—JAK2—ulcerative colitis	1.05e-05	8.51e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—STAT3—ulcerative colitis	1.02e-05	8.28e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS1—ulcerative colitis	1.02e-05	8.28e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MMP9—ulcerative colitis	1e-05	8.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—DLD—ulcerative colitis	1e-05	8.15e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1e-05	8.14e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PPARG—ulcerative colitis	9.99e-06	8.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	9.99e-06	8.12e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NFKB1—ulcerative colitis	9.93e-06	8.07e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—ulcerative colitis	9.92e-06	8.06e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS1—ulcerative colitis	9.85e-06	8.01e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—ulcerative colitis	9.85e-06	8.01e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.69e-06	7.87e-05	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.64e-06	7.83e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PPARG—ulcerative colitis	9.64e-06	7.83e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—JAK2—ulcerative colitis	9.62e-06	7.82e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.53e-06	7.74e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ABCB1—ulcerative colitis	9.49e-06	7.72e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—DLD—ulcerative colitis	9.45e-06	7.68e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—ulcerative colitis	9.44e-06	7.67e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—ulcerative colitis	9.4e-06	7.64e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CALM3—ulcerative colitis	9.17e-06	7.45e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADCY5—ulcerative colitis	9.13e-06	7.42e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—ulcerative colitis	9.12e-06	7.41e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ABCB1—ulcerative colitis	9.1e-06	7.4e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—ulcerative colitis	9.05e-06	7.36e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ALB—ulcerative colitis	8.98e-06	7.3e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS1—ulcerative colitis	8.96e-06	7.28e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PPARG—ulcerative colitis	8.96e-06	7.28e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—STAT3—ulcerative colitis	8.92e-06	7.25e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CALM3—ulcerative colitis	8.87e-06	7.21e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ADCY5—ulcerative colitis	8.86e-06	7.2e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.76e-06	7.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	8.67e-06	7.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ALB—ulcerative colitis	8.67e-06	7.04e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ADCY5—ulcerative colitis	8.49e-06	6.9e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.48e-06	6.89e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.38e-06	6.81e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—ulcerative colitis	8.27e-06	6.72e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PPARG—ulcerative colitis	8.14e-06	6.62e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—JAK2—ulcerative colitis	8.13e-06	6.61e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CALM3—ulcerative colitis	8.07e-06	6.56e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ALB—ulcerative colitis	8.06e-06	6.55e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ADCY5—ulcerative colitis	7.94e-06	6.46e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—ulcerative colitis	7.86e-06	6.39e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—ulcerative colitis	7.81e-06	6.35e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—ulcerative colitis	7.71e-06	6.26e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—STAT3—ulcerative colitis	7.68e-06	6.24e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—ulcerative colitis	7.65e-06	6.22e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—ulcerative colitis	7.58e-06	6.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ALB—ulcerative colitis	7.32e-06	5.95e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	7.22e-06	5.87e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CHP1—ulcerative colitis	7.15e-06	5.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCB1—ulcerative colitis	7.13e-06	5.8e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—ulcerative colitis	7.12e-06	5.79e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—ulcerative colitis	7.12e-06	5.78e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—ulcerative colitis	7.06e-06	5.74e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—ulcerative colitis	7.05e-06	5.73e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCB1—ulcerative colitis	6.9e-06	5.61e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—ulcerative colitis	6.81e-06	5.53e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.76e-06	5.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	6.74e-06	5.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—JAK2—ulcerative colitis	6.74e-06	5.47e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ADCY5—ulcerative colitis	6.65e-06	5.41e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—ulcerative colitis	6.61e-06	5.37e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS1—ulcerative colitis	6.57e-06	5.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—ulcerative colitis	6.54e-06	5.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RELA—ulcerative colitis	6.52e-06	5.3e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ADCY5—ulcerative colitis	6.44e-06	5.23e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—ulcerative colitis	6.41e-06	5.21e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—ulcerative colitis	6.33e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCB1—ulcerative colitis	6.28e-06	5.1e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—ulcerative colitis	6.23e-06	5.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—DLD—ulcerative colitis	6.18e-06	5.02e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CXCL8—ulcerative colitis	6.15e-06	5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—ulcerative colitis	5.97e-06	4.85e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	5.94e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ALB—ulcerative colitis	5.94e-06	4.83e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CALM3—ulcerative colitis	5.92e-06	4.81e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—ulcerative colitis	5.88e-06	4.78e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ADCY5—ulcerative colitis	5.85e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ALB—ulcerative colitis	5.69e-06	4.63e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—JAK2—ulcerative colitis	5.69e-06	4.63e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MMP9—ulcerative colitis	5.56e-06	4.52e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—ulcerative colitis	5.53e-06	4.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RELA—ulcerative colitis	5.51e-06	4.48e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NFKB1—ulcerative colitis	5.5e-06	4.47e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—ulcerative colitis	5.37e-06	4.36e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—ulcerative colitis	5.2e-06	4.22e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CXCL8—ulcerative colitis	5.19e-06	4.22e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—ulcerative colitis	4.98e-06	4.05e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—ulcerative colitis	4.96e-06	4.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—ulcerative colitis	4.96e-06	4.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—JAK2—ulcerative colitis	4.95e-06	4.03e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—ulcerative colitis	4.94e-06	4.02e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—ulcerative colitis	4.93e-06	4.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS1—ulcerative colitis	4.85e-06	3.94e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—ulcerative colitis	4.8e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—ulcerative colitis	4.7e-06	3.82e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—ulcerative colitis	4.7e-06	3.82e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—ulcerative colitis	4.66e-06	3.79e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NFKB1—ulcerative colitis	4.65e-06	3.78e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—ulcerative colitis	4.6e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—ulcerative colitis	4.58e-06	3.72e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.57e-06	3.71e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.53e-06	3.68e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—ulcerative colitis	4.46e-06	3.63e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—ulcerative colitis	4.37e-06	3.55e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CALM3—ulcerative colitis	4.36e-06	3.55e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—ulcerative colitis	4.32e-06	3.51e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADCY5—ulcerative colitis	4.29e-06	3.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—ulcerative colitis	4.18e-06	3.4e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—ulcerative colitis	4.17e-06	3.39e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CALM3—ulcerative colitis	4.11e-06	3.34e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—ulcerative colitis	3.93e-06	3.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—ulcerative colitis	3.9e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—ulcerative colitis	3.87e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—ulcerative colitis	3.78e-06	3.07e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—ulcerative colitis	3.77e-06	3.07e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—ulcerative colitis	3.64e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—ulcerative colitis	3.45e-06	2.81e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—ulcerative colitis	3.43e-06	2.79e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—ulcerative colitis	3.37e-06	2.74e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—ulcerative colitis	3.2e-06	2.6e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.2e-06	2.6e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—ulcerative colitis	3.19e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADCY5—ulcerative colitis	3.17e-06	2.57e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.99e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.98e-06	2.42e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—ulcerative colitis	2.92e-06	2.37e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—ulcerative colitis	2.88e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.69e-06	2.18e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—ulcerative colitis	2.54e-06	2.06e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—ulcerative colitis	2.52e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—ulcerative colitis	2.36e-06	1.92e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.22e-06	1.81e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—ulcerative colitis	2.12e-06	1.73e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.09e-06	1.7e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—ulcerative colitis	2e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.95e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—ulcerative colitis	1.86e-06	1.51e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.75e-06	1.42e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.45e-06	1.18e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—ulcerative colitis	1.31e-06	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.14e-06	9.3e-06	CbGpPWpGaD
